What is Debra Bailey's NPI number?

Debra Bailey's National Provider Identifier (NPI) is 1285622852, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Debra Bailey's specialty?

Debra Bailey is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Debra Bailey located?

Debra Bailey's practice location on file with NPPES is 2350 Vanderbilt Beach Rd, Naples, FL 34109-2760.

What is Debra Bailey's phone number?

The practice phone number listed in the NPPES registry for Debra Bailey is (239) 444-3376.

Does Debra Bailey accept Medicare?

Debra Bailey is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Debra Bailey's NPI active?

Yes — Debra Bailey's NPI (1285622852) is active in the NPPES registry as of the last update on 2016-03-04.

IndividualActiveAccepts Medicare

Debra Bailey, M.D.

NPI 1285622852 · Dermatology Physician · Naples, FL

Debra Bailey, M.D. is a Dermatology Physician provider in Naples, FL (NPI 1285622852).

Provider details

NPI number: 1285622852
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Female
Sole proprietor: Yes
License: D0041689 (MD)

Practice location

2350 Vanderbilt Beach Rd

Suite 301

Naples, FL 34109-2760

Phone: (239) 444-3376

Fax: (239) 316-3001

Street-level locationGet directions

More FL providers

Mailing address

2350 Vanderbilt Beach Rd

Naples, FL 34109-2760

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense ME106898 (FL)
Allopathic & Osteopathic Physicians
Dermatology Physician207N00000XLicense D0041689 (MD)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(94/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
21 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
12,855 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	3,236	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	2,471	$90
Superficial And/Or Low Voltage Radiation Treatment Delivery77401	1,307	$40
Destruction of Precancer Skin Growth, 1 Growth17000	837	$50
Biopsy of Related Skin Growth, First Growth11102	804	$86
Biopsy of Related Skin Growth, Each Additional Growth11103

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 9 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Clobetasol Propionate	135	91
Triamcinolone Acetonide	117	81
Doxycycline Hyclate	98	74
Valacyclovir Hclbrand: Valacyclovir	52	27
Mupirocin	33	27
Ketoconazole	20	13
Imiquimod	14	13
Cefuroxime Axetilbrand: Cefuroxime

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$445 across 18 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2005-10-07
Last updated: 2016-03-04

Frequently asked questions

What is Debra Bailey's NPI number?: Debra Bailey's National Provider Identifier (NPI) is 1285622852, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Debra Bailey's specialty?: Debra Bailey is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Debra Bailey located?: Debra Bailey's practice location on file with NPPES is 2350 Vanderbilt Beach Rd, Naples, FL 34109-2760.
What is Debra Bailey's phone number?: The practice phone number listed in the NPPES registry for Debra Bailey is (239) 444-3376.
Does Debra Bailey accept Medicare?: Debra Bailey is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Debra Bailey's NPI active?: Yes — Debra Bailey's NPI (1285622852) is active in the NPPES registry as of the last update on 2016-03-04.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	3,236	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	2,471	$90
Superficial And/Or Low Voltage Radiation Treatment Delivery77401	1,307	$40
Destruction of Precancer Skin Growth, 1 Growth17000	837	$50
Biopsy of Related Skin Growth, First Growth11102	804	$86
Biopsy of Related Skin Growth, Each Additional Growth11103

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 9 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Clobetasol Propionate	135	91
Triamcinolone Acetonide	117	81
Doxycycline Hyclate	98	74
Valacyclovir Hclbrand: Valacyclovir	52	27
Mupirocin	33	27
Ketoconazole	20	13
Imiquimod	14	13
Cefuroxime Axetilbrand: Cefuroxime

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$445 across 18 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments